SCHEDULE: Lagoda Investment Boosts VolitionRX Stake to 11.3%
Beneficial Ownership Report
Lagoda Investment Management, L.P. has increased its beneficial ownership in VolitionRX Ltd to 11.3% of common stock as of June 30, 2025.
Summary
- Lagoda Investment Management, L.P. (the "Reporting Person") has filed an Amendment No. 3 to Schedule 13G regarding its beneficial ownership in VolitionRX Ltd.
- As of June 30, 2025, the Reporting Person beneficially owned 11,705,000 shares of VolitionRX Ltd's common stock.
- This ownership represents 11.3% of the total 103,982,020 shares of common stock outstanding as of June 30, 2025, as disclosed in VolitionRX Ltd's Registration Statement on Form S-3 filed on July 3, 2025.
- The Reporting Person, an investment adviser, holds sole voting and sole dispositive power over these shares, which are held in managed accounts.
Sentiment
Score: 5
Explanation: This filing is a routine disclosure of beneficial ownership and does not contain operational or financial performance data to assess sentiment. It is a factual report of an investment firm's stake.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- NA
Industry Context
This filing reflects a significant ownership stake by an investment management firm in a publicly traded company, which is a common occurrence in the financial markets. It indicates an institutional investor's position in the company's equity.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- This filing primarily impacts shareholders by disclosing a significant institutional ownership stake, which can influence market perception and trading activity.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement, representing the snapshot of beneficial ownership. |
| 07/03/2025 | Date VolitionRX Ltd filed its Registration Statement on Form S-3, disclosing shares outstanding. |
| 08/14/2025 | Date the Schedule 13G Amendment No. 3 was signed and filed by Lagoda Investment Management, L.P. |
Keywords
VolitionRX Ltd, Lagoda Investment Management, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Investment Management, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.